Sign in
4

Changes in Ownership

Obsidian Therapeutics, Inc. Filed Acc 0001193125-26-335083

Options or other derivatives

  • Director acquired 37,653 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Norkunas Matthew Director 2026-08-03 Grant or award · Stock Option (Right to Buy) +37,653 37,653 D
Loading xslF345X06/ownership.xml…